110 related articles for article (PubMed ID: 29518423)
1. Association between (CCTTT)n repeat polymorphism in NOS2 promoter and asthma exacerbations.
Hirai K; Shirai T; Suzuki M; Shimomura T; Itoh K
J Allergy Clin Immunol; 2018 Aug; 142(2):663-665.e3. PubMed ID: 29518423
[No Abstract] [Full Text] [Related]
2. Exhaled nitric oxide and inducible nitric oxide synthase gene polymorphism in Japanese asthmatics.
Sato S; Wang X; Saito J; Fukuhara A; Uematsu M; Suzuki Y; Sato Y; Misa K; Nikaido T; Fukuhara N; Tanino Y; Munakata M
Allergol Int; 2016 Jul; 65(3):300-5. PubMed ID: 27021121
[TBL] [Abstract][Full Text] [Related]
3. (CCTTT)n repeat polymorphism in the NOS2 gene promoter is associated with atopy.
Konno S; Hizawa N; Yamaguchi E; Jinushi E; Nishimura M
J Allergy Clin Immunol; 2001 Nov; 108(5):810-4. PubMed ID: 11692109
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between NOS2 pentanucleotide repeat polymorphism and asthma phenotypes or exhaled nitric oxide concentration.
Leung TF; Liu EK; Li CY; Chan IH; Yung E; Lam CW; Wong GW
Pediatr Pulmonol; 2006 Jul; 41(7):649-55. PubMed ID: 16703578
[TBL] [Abstract][Full Text] [Related]
5. (CCTTT)n polymorphism of NOS2A in nasal polyposis and asthma: a case-control study.
Pascual M; Sanz C; Isidoro-García M; Dávila I; Moreno E; Laffond E; Lorente F
J Investig Allergol Clin Immunol; 2008; 18(4):239-44. PubMed ID: 18714530
[TBL] [Abstract][Full Text] [Related]
6. Association of inducible nitric oxide synthase with asthma severity, total serum immunoglobulin E and blood eosinophil levels.
Batra J; Pratap Singh T; Mabalirajan U; Sinha A; Prasad R; Ghosh B
Thorax; 2007 Jan; 62(1):16-22. PubMed ID: 17189532
[TBL] [Abstract][Full Text] [Related]
7. Association of the pentanucleotide repeat polymorphism in NOS2 promoter region with susceptibility to migraine in a Chinese population.
Jia S; Ni J; Chen S; Jiang Y; Dong W; Gao Y
DNA Cell Biol; 2011 Feb; 30(2):117-22. PubMed ID: 20874490
[TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase gene promoter polymorphism is associated with increased gastric mRNA expression of inducible nitric oxide synthase and increased risk of gastric carcinoma.
Kaise M; Miwa J; Suzuki N; Mishiro S; Ohta Y; Yamasaki T; Tajiri H
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):139-45. PubMed ID: 17272999
[TBL] [Abstract][Full Text] [Related]
9. The promoter of inducible nitric oxide synthase implicated in glaucoma based on genetic analysis and nuclear factor binding.
Motallebipour M; Rada-Iglesias A; Jansson M; Wadelius C
Mol Vis; 2005 Nov; 11():950-7. PubMed ID: 16288199
[TBL] [Abstract][Full Text] [Related]
10. Survey of the allelic frequency of a NOS2A promoter microsatellite in human populations: assessment of the NOS2A gene and predisposition to infectious disease.
Xu W; Humphries S; Tomita M; Okuyama T; Matsuki M; Burgner D; Kwiatkowski D; Liu L; Charles IG
Nitric Oxide; 2000 Aug; 4(4):379-83. PubMed ID: 10944422
[TBL] [Abstract][Full Text] [Related]
11. NOS2A promoter (CCTTT)n association with TB lacks independent functional correlation amongst Indians.
Jena M; Srivastava AK; Singh RK; Sharma PR; Das PK; Bamezai RN
Tuberculosis (Edinb); 2014 Jan; 94(1):81-6. PubMed ID: 24291065
[TBL] [Abstract][Full Text] [Related]
12. Association Between rs3833912/rs16944 SNPs and Risk for Cerebral Palsy in Mexican Children.
Torres-Merino S; Moreno-Sandoval HN; Thompson-Bonilla MDR; Leon JAO; Gomez-Conde E; Leon-Chavez BA; Martinez-Fong D; Gonzalez-Barrios JA
Mol Neurobiol; 2019 Mar; 56(3):1800-1811. PubMed ID: 29931509
[TBL] [Abstract][Full Text] [Related]
13. The (CCTTT)n microsatellite polymorphism in the nitric oxide synthase 2 gene may influence bladder cancer pathogenesis.
Ryk C; Steineck G; Wiklund NP; Nyberg T; de Verdier PJ
J Urol; 2010 Nov; 184(5):2150-7. PubMed ID: 20850837
[TBL] [Abstract][Full Text] [Related]
14. Association evidence of CCTTT repeat polymorphism in the iNOS promoter and the risk of atrial fibrillation in Taiwanese.
Hsu LA; Yeh YH; Chen WJ; Kuo CT; Tsai FC; Chan YH; Wang CL; Chang CJ; Tsai HY
Sci Rep; 2017 Feb; 7():42388. PubMed ID: 28205526
[TBL] [Abstract][Full Text] [Related]
15. The (CCTTT) n pentanucleotide repeat polymorphism in the inducible nitric oxide synthase gene promoter and the risk of psoriasis in Taiwanese.
Chang YC; Wu WM; Huang YH; Chung WH; Tsai HY; Hsu LA
Arch Dermatol Res; 2015 Jul; 307(5):425-32. PubMed ID: 25663087
[TBL] [Abstract][Full Text] [Related]
16. Significant association of longer forms of CCTTT Microsatellite repeat in the inducible nitric oxide synthase promoter with severe malaria in Thailand.
Ohashi J; Naka I; Patarapotikul J; Hananantachai H; Looareesuwan S; Tokunaga K
J Infect Dis; 2002 Aug; 186(4):578-81. PubMed ID: 12195390
[TBL] [Abstract][Full Text] [Related]
17. No evidence for association of the inducible nitric oxide synthase promoter polymorphism with Trypanosoma cruzi infection.
Calzada JE; López-Nevot MA; Beraún Y; Martín J
Tissue Antigens; 2002 Apr; 59(4):316-9. PubMed ID: 12135432
[TBL] [Abstract][Full Text] [Related]
18. Inducible nitric oxide synthase (NOS2) promoter CCTTT repeat polymorphism: relationship to in vivo nitric oxide production/NOS activity in an asymptomatic malaria-endemic population.
Boutlis CS; Hobbs MR; Marsh RL; Misukonis MA; Tkachuk AN; Lagog M; Booth J; Granger DL; Bockarie MJ; Mgone CS; Levesque MC; Weinberg JB; Anstey NM
Am J Trop Med Hyg; 2003 Dec; 69(6):569-73. PubMed ID: 14740870
[TBL] [Abstract][Full Text] [Related]
19. Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritis.
Gonzalez-Gay MA; Oliver J; Sanchez E; Garcia-Porrua C; Paco L; Lopez-Nevot MA; Ollier WE; Martin J
J Rheumatol; 2005 Nov; 32(11):2178-82. PubMed ID: 16265698
[TBL] [Abstract][Full Text] [Related]
20. The inducible nitric oxide synthase promoter polymorphism does not confer susceptibility to systemic lupus erythematosus.
López-Nevot MA; Ramal L; Jiménez-Alonso J; Martín J
Rheumatology (Oxford); 2003 Jan; 42(1):113-6. PubMed ID: 12509623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
